Novel Dopamine D3 Receptor Antagonist Reduces Opioid Addiction-Like Behaviors in Rats
The dopamine D3 receptor antagonist VK4-116 reduced oxycodone self-administration in rats, as well as drug-seeking behaviors after oxycodone reinstatement following withdrawal. VK4-116 did not interfere with oxycodone ’s pain-relieving effects (Source: NIDA News)
Source: NIDA News - January 13, 2020 Category: Addiction Tags: NIDA Notes, Opioids, Basic Science, Treatment Research, Pain, Addiction Science Source Type: news

FDA documents analysis reveals inadequate monitoring of safe opioid use program
(Johns Hopkins University Bloomberg School of Public Health) A risk-management program set up in 2012 by the US Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health. Extended-release and long-acting opioids, which include oxycontin, account for a significant proportion of the prescription opioid market and are among the most misused. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 7, 2020 Category: International Medicine & Public Health Source Type: news

Opioid Use By Teens a Red Flag for Other Dangers
In a national survey of U.S. high school students, 14% said they had ever "misused" a prescription opioid such as Vicodin, OxyContin or Percocet. (Source: WebMD Health)
Source: WebMD Health - January 6, 2020 Category: Consumer Health News Source Type: news

Meds2Go Express Pharmacy, Inc. Pleads Guilty to Money Laundering in Connection with Drug Diversion Scheme
Alum Creek WV, Meds2Go Express Pharmacy, plea, guilty, money laundering, drug diversion, pain clinic, pill mill, opioids, community restitution, drug abuse treatment, Rx opioids, red flags, oxycodone, drug addicts, methadone, compounding, Charleston WV, forfeiture, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - January 6, 2020 Category: Medical Law Authors: DOJ Source Type: news

As Tens of Thousands Died, F.D.A. Failed to Police Opioids
The agency, whose oversight of opioid safety has largely eluded scrutiny, did not improve flawed programs designed to reduce addiction and overdoses, documents show. (Source: NYT Health)
Source: NYT Health - December 31, 2019 Category: Consumer Health News Authors: Abby Goodnough and Margot Sanger-Katz Tags: Opioids and Opiates OxyContin (Drug) Drugs (Pharmaceuticals) Pain-Relieving Drugs Fentanyl Regulation and Deregulation of Industry Food and Drug Administration your-feed-healthcare Drug Abuse and Traffic Source Type: news

Want OxyContin in China? Pain pill addicts get drugs online
Officially, China doesn't have an opioid problem like the United States (Source: ABC News: Health)
Source: ABC News: Health - December 31, 2019 Category: Consumer Health News Tags: Health Source Type: news

F.D.A. Failed to Ensure Safe Prescribing of Opioids, Documents Show
The agency, whose oversight of opioid safety has largely eluded scrutiny, did not improve flawed programs designed to reduce addiction and overdoses. (Source: NYT)
Source: NYT - December 31, 2019 Category: American Health Authors: Abby Goodnough and Margot Sanger-Katz Tags: Opioids and Opiates OxyContin (Drug) Drugs (Pharmaceuticals) Pain-Relieving Drugs Fentanyl Regulation and Deregulation of Industry Food and Drug Administration your-feed-healthcare Source Type: news

Havertown Doctor Pleads Guilty to Unlawfully Importing Foreign, Injectable Drugs and Unlawfully Distributing Oxycodone
Thomas Whalen, Havertown PA, Guilty plea, importation, heath care fraud, oxycodone, D.O., controlled substance, Whalen Rheumatology Group, Exton PA, Wilmington DE, Unapproved, Injection, Infusion, Remicade Synvisc, Synvisc-One, Orencia, Prolia/Xgeva, Boniva (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - December 19, 2019 Category: Medical Law Authors: DOJ Source Type: news

Sacklers Withdrew Over $12 Billion From Purdue Pharma As The Opioid Epidemic Grew
Recently released court documents highlight an audit that found the Sackler family withdrew $10.7 billion from Purdue Pharma between the 2008 to 2017 as scrutiny over the opioid epidemic and the company ’s signature drug OxyContin grew. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 18, 2019 Category: Pharmaceuticals Authors: Clary Estes, Contributor Source Type: news

Sacklers Withdrew Over $12 Billion Over 13 Years From Purdue Pharma As The Opioid Epidemic Grew
Recently released court documents highlight an audit that found the Sackler family withdrew $10.7 billion from Purdue Pharma between the 2008 to 2017 as scrutiny over the opioid epidemic and the company ’s signature drug OxyContin grew. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 18, 2019 Category: Pharmaceuticals Authors: Clary Estes, Contributor Source Type: news

Sacklers withdrew over $10 billion in a decade from Purdue Pharma: New York Times
The Sackler family - owners of Purdue Pharma - transferred more than $10 billion in a decade from the OxyContin maker to its trusts and holding companies, the New York Times reported on Monday, citing a new audit commissioned by the drugmaker. (Source: Reuters: Health)
Source: Reuters: Health - December 17, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Owners of Purdue Pharma took more money from opioid-producing company after being fined for misleading public
The wealthy owners of OxyContin maker Purdue Pharma started taking far more money out of the company after it was fined for misleading marketing of the powerful prescription painkiller. (Source: CBC | Health)
Source: CBC | Health - December 17, 2019 Category: Consumer Health News Tags: News/World Source Type: news

Sacklers withdrew over $10 billion in a decade from Purdue Pharma: NYT
The Sackler family - owners of Purdue Pharma - transferred more than $10 billion in a decade from the OxyContin maker to its trusts and holding companies, the New York Times reported on Monday, citing a new audit commissioned by the drugmaker. (Source: Reuters: Health)
Source: Reuters: Health - December 17, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Suspended Pharmacist Charged with Health Care Fraud Conspiracy, Fraudulently Obtaining Controlled Substances and Misbranding Drugs
pharmacist, suspended, health care fraud, conspiracy, controlled substances, misbranded drugs, indictment, Timothy Forester, Venetia PA, Pittsburgh, South Hills, oxycodone, hydrocodone, deception, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - December 13, 2019 Category: Medical Law Authors: DOJ Source Type: news

U.S. Supreme Court rejects Arizona opioid case against Purdue, Sackler family
The U.S. Supreme Court on Monday turned away a novel case by Arizona seeking to recover billions of dollars that the state has said that members of the Sackler family - owners of Purdue Pharma LP - funneled out of the OxyContin maker before the company filed for bankruptcy in September. (Source: Reuters: Health)
Source: Reuters: Health - December 9, 2019 Category: Consumer Health News Tags: healthNews Source Type: news